Literature DB >> 33666692

Intra-prefrontal cyclosporine potentiates ketamine-induced fear extinction in rats.

Ahmad Mohammadi-Farani1,2, Negin Tamasoki3, Reza Rahimian4.   

Abstract

Several brain regions, including the medial prefrontal cortex (mPFC), are important in the process of fear extinction learning. Ketamine is a glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, which is shown to play a role in extinction modulation. Ketamine and calcineurin (CN), an intracellular protein phosphatase, have several common targets in the cells. Therefore, in the present study, our aim is to investigate the possible role of calcineurin in the mPFC on the enhancing effects of ketamine in fear extinction. First, different doses of a CN inhibitor, cyclosporine-A (CsA), were micro-injected into the infralimbic (IL) region of the mPFC prior to extinction training in a classical conditioning model in rats. Next, sub-effective doses of CsA (Intra-mPFC) and ketamine (i.p.) were co-administered in another cohort of rats to find their possible interactions. Enzymatic activity of calcineurin was measured in the IL-mPFC following drug administration. We used the elevated plus-maze (EPM) and open field (OF) test for further behavioral assessments. The results showed that CsA can enhance the extinction of conditioned fear and inhibit the enzyme CN at a dose of 20 nM. The combination of sub-effective doses of CsA (5 nM) and ketamine (10 mg/kg) could again enhance the extinction of fear and reduce CN activity in the region. Our results propose that inhibition of CN in the IL-mPFC is involved in the extinction of fear and ketamine enhancement of extinction is probably mediated by reducing CN activity in this part of the brain.

Entities:  

Keywords:  Cyclosporine-A; Fear extinction; Ketamine; Medial prefrontal cortex

Year:  2021        PMID: 33666692     DOI: 10.1007/s00221-021-06050-7

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  55 in total

1.  Hippocampal train stimulation modulates recall of fear extinction independently of prefrontal cortex synaptic plasticity and lesions.

Authors:  Mélissa Farinelli; Olivier Deschaux; Sandrine Hugues; Aurélie Thevenet; René Garcia
Journal:  Learn Mem       Date:  2006 May-Jun       Impact factor: 2.460

2.  Reconsolidation or extinction: transcription factor switch in the determination of memory course after retrieval.

Authors:  Verónica de la Fuente; Ramiro Freudenthal; Arturo Romano
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

3.  Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion.

Authors:  Daniel D'Andrea; R Andrew Sewell
Journal:  Biol Psychiatry       Date:  2013-05-23       Impact factor: 13.382

4.  Effects of ketamine on different types of anxiety/fear and related memory in rats with lesions of the median raphe nucleus.

Authors:  E Babar; T Ozgünen; E Melik; S Polat; H Akman
Journal:  Eur J Pharmacol       Date:  2001-11-23       Impact factor: 4.432

5.  Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

Authors:  Adriana Feder; Michael K Parides; James W Murrough; Andrew M Perez; Julia E Morgan; Shireen Saxena; Katherine Kirkwood; Marije Aan Het Rot; Kyle A B Lapidus; Le-Ben Wan; Dan Iosifescu; Dennis S Charney
Journal:  JAMA Psychiatry       Date:  2014-06       Impact factor: 21.596

6.  Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.

Authors:  E Engin; D Treit; C T Dickson
Journal:  Neuroscience       Date:  2009-03-24       Impact factor: 3.590

Review 7.  Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine.

Authors:  Anna C Donoghue; Mark G Roback; Kathryn R Cullen
Journal:  Pediatrics       Date:  2015-08-10       Impact factor: 7.124

8.  Glutamatergic targets for enhancing extinction learning in drug addiction.

Authors:  R M Cleva; J T Gass; J J Widholm; M F Olive
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

9.  NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Authors:  Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

10.  Previous Ketamine Produces an Enduring Blockade of Neurochemical and Behavioral Effects of Uncontrollable Stress.

Authors:  Jose Amat; Samuel D Dolzani; Scott Tilden; John P Christianson; Kenneth H Kubala; Kristi Bartholomay; Katherine Sperr; Nicholas Ciancio; Linda R Watkins; Steven F Maier
Journal:  J Neurosci       Date:  2016-01-06       Impact factor: 6.167

View more
  1 in total

1.  Intra-mPFC injection of sodium butyrate promotes BDNF expression and ameliorates extinction recall impairment in an experimental paradigm of post-traumatic stress disorder.

Authors:  Ahmad Mohammadi-Farani; Sajad Fakhri; Cyrus Jalili; Zahra Samimi
Journal:  Iran J Basic Med Sci       Date:  2022-09       Impact factor: 2.532

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.